We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Increased Baseline C-Reactive Protein Linked to Heightened Infection Risk

By LabMedica International staff writers
Posted on 01 Feb 2016
C-reactive protein (CRP) is an innate immune system recognition and effector molecule that plays a role in both the innate response and as an adaptor to the complex immune system. More...


In an infectious disease or inflammatory state, rapid CRP upregulation occurs and the most pronounced increases are primarily seen in infectious diseases and the acute-phase CRP increases rapidly during an infection.

Clinical biochemists at the Copenhagen University Hospital (Denmark) studied 9,660 individuals from a prospective general population cohort, including 3,592 in whom infectious disease developed, and another 60,896 individuals from a cross-sectional general population study, of whom 13,332 developed infectious disease; 55% were women, and the mean age was 57 years. Infectious diseases were classified as bacterial, viral, or other.

The ABI Prism 7900HT SDS (Applied Biosystems; Foster City, CA, USA) was used to genotype for four single nucleotide polymorphisms in the CRP gene (rs3091244, rs1130864, rs1205, and rs3093077). Genotyping was verified by DNA sequencing in more than 30 individuals with each genotype. CRP was measured with high-sensitivity nephelometry or turbidimetry assays. Covariates for adjustments were chosen on the basis of known influence on plasma CRP concentrations or risk of infection.

The teams found that individuals with CRP greater than 3 mg/L had 1.2 and 1.7 times increased risk of infectious disease, in the prospective general population cohort and the cross-sectional general population study, respectively, compared with individuals with CRP of less than 1 mg/L. In the combined populations, individuals in the highest CRP tertile compared with the lowest had an increased risk of bacterial diseases, but not viral, mycosis, and parasitic diseases. The increased risk was mainly carried by pneumonia, sepsis, and particularly gram-negative infections. None of the genotype combinations examined conferred an increased risk of infectious disease.

The authors concluded that chronic low-level increased plasma CRP concentrations to be associated with an increased risk of bacterial infections, and in particular gram-negative infections. However, genotypes associated with increases in plasma CRP concentrations were not associated with increased risk of infection. The study was published on December 31, 2015, in the journal Clinical Chemistry.

Related Links:

Copenhagen University Hospital 
Applied Biosystems



Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Serological Pipet Controller
PIPETBOY GENIUS
New
Automatic Hematology Analyzer
LABAS F9000
New
Chlamydia Trachomatis Test
Aptima Chlamydia Trachomatis Assay
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Molecular Diagnostics

view channel
Image: New research brings hope for improved early detection of pancreatic cancer (Photo courtesy of Adobe Stock)

New Biomarker Panel to Enable Early Detection of Pancreatic Cancer

Pancreatic cancer (PC) has one of the worst prognoses globally, with only 13% of diagnosed patients surviving for five years or more. In Ireland, there are about 900 cases of pancreatic cancer annually,... Read more

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.